FTC Says Cephalon Bought Off Would-Be Competitors
The U.S. Federal Trade Commission has filed a lawsuit against Cephalon Inc. that alleges the pharmaceutical company paid off four would-be generics competitors to keep them out of the $800 million...To view the full article, register now.
Already a subscriber? Click here to view full article